| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $0.0100 | 02 Apr 2025 | Direct |
| Traws Pharma, Inc. | 10%+ Owner | Pre-Funded Warrant (right to buy) | 96,348 | 29 Dec 2024 | Direct | ||
| Traws Pharma, Inc. | 10%+ Owner | Series A Warrant (right to buy) | 96,348 | 29 Dec 2024 | Direct | ||
| Traws Pharma, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | 02 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | 02 Apr 2025 | 2 | $0 | 4 | 10%+ Owner | 08 Apr 2025, 20:32 |
| TRAW | Traws Pharma, Inc. | 29 Dec 2024 | 2 | $0 | 4 | 10%+ Owner | 27 Jan 2025, 19:01 |
| TRAW | Traws Pharma, Inc. | 01 Apr 2024 | 0 | $0 | 3/A | 10%+ Owner | 11 Apr 2024, 17:41 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 0 | $0 | 3 | 10%+ Owner | 03 Apr 2024, 19:51 |